cancer
AI tool finds cancer signs missed by doctors
An AI tool has proven capable of detecting signs of cancer that were overlooked by human radiologists. The AI tool, called Mia, was piloted alongside NHS clinicians in the UK and analysed the mammograms of over 10,000 women. Most of the participants were cancer-free, but the AI successfully flagged all of those with symptoms of…
Five MIT faculty members take on Cancer Grand Challenges | MIT News
Cancer Grand Challenges recently announced five winning teams for 2024, which included five researchers from MIT: Michael Birnbaum, Regina Barzilay, Brandon DeKosky, Seychelle Vos, and Ömer Yilmaz. Each team is made up of interdisciplinary cancer researchers from across the globe and will be awarded $25 million over five years. Birnbaum, an associate professor in the…
New hope for early pancreatic cancer intervention via AI-based risk prediction | MIT News
The first documented case of pancreatic cancer dates back to the 18th century. Since then, researchers have undertaken a protracted and challenging odyssey to understand the elusive and deadly disease. To date, there is no better cancer treatment than early intervention. Unfortunately, the pancreas, nestled deep within the abdomen, is particularly elusive for early detection. …
Reindeer’s real superpowers could help us beat depression and cancer
AS ANY young child knows, reindeer have a special superpower: they can fly. Or, at least, Rudolph and his eight sleigh-towing pals can. Reindeer first took to the skies in 1823, when Clement Clarke Moore published Twas the Night Before Christmas. He is said to have got his inspiration from the Sami people of northern…
Absci and AstraZeneca forge AI partnership to discover cancer treatments
Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment. This collaboration will capitalise on Absci’s Integrated Drug Creation platform—seamlessly integrating with AstraZeneca’s expertise in oncology, aiming to expedite the discovery of a potentially game-changing cancer therapy. Under the agreement,…